Geneos Wealth Management
CONE

Geneos Wealth Management’s CyrusOne Inc Common Stock CONE Stock Holding History

Geneos Wealth Management’s Portfolio CONE Stock Details CONE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-71
Closed -$6K – 3064
2021
Q4 		$6K Sell
71
-350
-83% -$29.7K ﹤0.01% 2385
2021
Q3 		$32K Buy
421
+1
+0.2% +$75 ﹤0.01% 1705
2021
Q2 		$29K Sell
420
-2
-0.5% -$146 ﹤0.01% 1740
2021
Q1 		$30K Buy
422
+2
+0.5% +$139 ﹤0.01% 1886
2020
Q4 		$28K Buy
420
+350
+500% +$25.4K ﹤0.01% 1741
2020
Q3 		$5K Hold
70
– – ﹤0.01% 2218
2020
Q2 		$5K Sell
70
-25
-26% -$1.78K ﹤0.01% 2184
2020
Q1 		$5K Hold
95
– – ﹤0.01% 2070
2019
Q4 		$6K Hold
95
– – ﹤0.01% 2161
2019
Q3 		$7K Hold
95
– – ﹤0.01% 2037
2019
Q2 		$5K Hold
95
– – ﹤0.01% 2140
2019
Q1 		$4K Buy
95
+5
+6% +$262 ﹤0.01% 2124
2018
Q4 		$4K Hold
90
– – ﹤0.01% 2085
2018
Q3 		$5K Hold
90
– – ﹤0.01% 2089
2018
Q2 		$5K Hold
90
– – ﹤0.01% 1946
2018
Q1 		$4K Hold
90
– – ﹤0.01% 1928
2017
Q4 		$5K Hold
90
– – ﹤0.01% 1846
2017
Q3 		$5K Hold
90
– – ﹤0.01% 1782
2017
Q2 		$5K Hold
90
– – ﹤0.01% 1751
2017
Q1 		$4K Sell
90
-25
-22% -$1.23K ﹤0.01% 1774
2016
Q4 		$5K Hold
115
– – ﹤0.01% 1666
2016
Q3 		$5K Buy
115
+25
+28% +$1.29K ﹤0.01% 1606
2016
Q2 		$4K Hold
90
– – ﹤0.01% 1597
2016
Q1 		$4K Buy
+90
New +$3.44K ﹤0.01% 1578

Other funds holding CONE

JCM
Jag Capital Management St Louis, Missouri $1.07B AUM 60.59% 1-Year Est. Return
KA
Kozak & Associates Highlands Ranch, Colorado $576M AUM 23.37% 1-Year Est. Return

Geneos Wealth Management's CONE Position: Q1 2022 in Review

Geneos Wealth Management sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 71 shares — an estimated $6K sold.

Geneos Wealth Management first reported a position in CONE in Q1 2016 and held it in 24 quarters. The position peaked at $32K in Q3 2021. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.

  • Geneos Wealth Management reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 71 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $6K.
  • Geneos Wealth Management first reported a position in CyrusOne Inc Common Stock in Q1 2016 and held it in 24 quarters.
  • Geneos Wealth Management's CyrusOne Inc Common Stock position peaked at $32K in Q3 2021.
  • 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.

Based on Geneos Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.